Principal Clinical Pharmacist, Hertfordshire Partnership University NHS Foundation Trust
The implications of the Montgomery judgment on pharmacy practice and patients with learning disabilitySubscription
The judgment in Montgomery v Lanarkshire (Scotland) 2015 introduced a new definition of informed consent which has implications for all healthcare professionals. This article focuses specifically on the implications for pharmacy practice and patients with learning disability. During consultations, both pharmacist prescribers and non-prescribing pharmacists must adhere to the provisions of the judgment to ensure patients provide informed consent. Particular issues arise where patients with lea
Pharmacists and healthcare professionals are ideally placed to review and reduce inappropriate prescribing of psychotropic medicines in people with learning disabilities safely and effectively.
Pharmacists’ role in optimising the use of medicines in those with learning disabilitiesSubscription
Following on from the response to the Winterbourne View Hospital scandal, where it was discovered many patients suffered serious abuse, the re-evaluation of antipsychotic use in people with learning disabilities has begun, with three separate reports commissioned by NHS England plus a study by Sheehan et al published in The BMJ in September 2015 (